139 related articles for article (PubMed ID: 11838809)
1. Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities.
Stubbs JB; Frankel RH; Schultz K; Crocker I; Dillehay D; Olson JJ
J Neurosurg; 2002 Feb; 96(2):335-43. PubMed ID: 11838809
[TBL] [Abstract][Full Text] [Related]
2. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins.
Dempsey JF; Williams JA; Stubbs JB; Patrick TJ; Williamson JF
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):421-9. PubMed ID: 9788425
[TBL] [Abstract][Full Text] [Related]
4. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator.
Monroe JI; Dempsey JF; Dorton JA; Mutic S; Stubbs JB; Markman J; Williamson JF
Med Phys; 2001 Jan; 28(1):73-85. PubMed ID: 11213925
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
7. The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.
Wernicke AG; Sherr DL; Schwartz TH; Pannullo SC; Stieg PE; Boockvar JA; Moliterno JA; Ivanidze J; Trichter S; Sabbas AM; Parashar B; Nori D
Brachytherapy; 2010; 9(1):91-9. PubMed ID: 19850535
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and dosimetry of an aqueous solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (Iotrex) for brachytherapy of resected malignant brain tumors.
Stubbs JB; Strickland AD; Frank RK; Simón J; McMillan K; Williams JA
Cancer Biother Radiopharm; 2000 Dec; 15(6):645-56. PubMed ID: 11190496
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System.
Chino K; Silvain D; Grace A; Stubbs J; Stea B
Med Phys; 2008 Jul; 35(7):3383-8. PubMed ID: 18697562
[TBL] [Abstract][Full Text] [Related]
10. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases.
Rogers LR; Rock JP; Sills AK; Vogelbaum MA; Suh JH; Ellis TL; Stieber VW; Asher AL; Fraser RW; Billingsley JS; Lewis P; Schellingerhout D; Shaw EG;
J Neurosurg; 2006 Sep; 105(3):375-84. PubMed ID: 16961129
[TBL] [Abstract][Full Text] [Related]
11. Radiation safety considerations in GliaSite 125I brain implant procedures.
Strzelczyk J; Safadi R
Health Phys; 2004 May; 86(5 Suppl):S120-3. PubMed ID: 15069303
[TBL] [Abstract][Full Text] [Related]
12. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
13. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy.
Keisch M; Vicini F; Kuske RR; Hebert M; White J; Quiet C; Arthur D; Scroggins T; Streeter O
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):289-93. PubMed ID: 12527040
[TBL] [Abstract][Full Text] [Related]
14. Balloon brachytherapy for brain tumor-radiation safety experiences at the University of Medicine and Dentistry of New Jersey.
Lanka VK
Health Phys; 2006 Nov; 91(5 Suppl):S83-6. PubMed ID: 17023804
[TBL] [Abstract][Full Text] [Related]
15. Novel use of the Contura for high dose rate cranial brachytherapy.
Scanderbeg DJ; Alksne JF; Lawson JD; Murphy KT
Med Dosim; 2011; 36(4):344-6. PubMed ID: 21144735
[TBL] [Abstract][Full Text] [Related]
16. Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
Hepel JT; Hiatt JR; Cardarelli GA; Wazer DE
Brachytherapy; 2010; 9(1):81-5. PubMed ID: 19850533
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
[TBL] [Abstract][Full Text] [Related]
18. An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy.
Hirschberg H; Madsen S; Lote K; Pham T; Tromberg B
J Neurooncol; 1999 Aug; 44(1):15-21. PubMed ID: 10582664
[TBL] [Abstract][Full Text] [Related]
19. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
